Perkins Capital Management’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11K | Sell |
|
|||||
|
2023
Q1 | $766K | Buy |
|
|||||
|
2022
Q4 | $30K | Sell |
|
|||||
|
2022
Q3 | $321K | Buy |
|
|||||
|
2022
Q2 | $542K | Sell |
|
|||||
|
2022
Q1 | $1.08M | Buy |
|
|||||
|
2021
Q4 | $1.19M | Sell |
|
|||||
|
2021
Q3 | $2M | Buy |
|
|||||
|
2021
Q2 | $2.18M | Buy |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q4 | $507K | Buy |
|
|||||
|
2020
Q3 | $306K | Buy |
|
|||||
|
2020
Q1 | $518K | Buy |
|
|||||
|
2019
Q4 | $729K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $849K | Sell |
|
|||||
|
2014
Q3 | $826K | Hold |
|
|||||
|
2014
Q2 | $742K | Sell |
|
|||||
|
2014
Q1 | $860K | Buy |
|
|||||
|
2013
Q4 | $537K | Sell |
|
|||||
|
2013
Q3 | $434K | Buy |
|